Details
Final Biosimilar Summary Dossier Issued:
Question
- What is the diagnostic test accuracy of positron emission tomography-computed tomography (PET-CT) in patients with Giant Cell Arteritis (GCA) or Takayasu’s vasculitis?
- What is the clinical utility of positron emission tomography-computed tomography (PET-CT) in patients with Giant Cell Arteritis (GCA) or Takayasu’s vasculitis?
- What is the cost-effectiveness of positron emission tomography-computed tomography (PET-CT) in patients with Giant Cell Arteritis or Takayasu’s vasculitis?
- What are the evidence-based guidelines associated with the use of positron-emission tomography-computed tomography (PET-CT) in patients with Giant Cell Arteritis (CGA) or Takayasu’s vasculitis?
Key Message
Four non-randomized studies were identified regarding fluorodeoxyglucose positron emission tomography-computed tomography (FDG PET-CT) for patients with Giant Cell Arteritis (GCA). No evidence was identified for Takayasu's vasculitis. No economic evaluations or evidence-based guidelines were identified.